Soleno Therapeutics to Participate in Upcoming September Conferences
Soleno Therapeutics (NASDAQ: SLNO), a biopharmaceutical company focused on rare disease therapeutics, has announced its participation in five major healthcare investor conferences during September 2025.
The company will present at the Cantor Global Healthcare Conference (Sept 3), Wells Fargo Healthcare Conference (Sept 4), H.C. Wainwright Global Investment Conference (Sept 8), Baird Global Healthcare Conference (Sept 9), and Bernstein Healthcare Forum (Sept 25). All presentations will be in fireside chat format.
Webcasts for the Cantor and Wells Fargo events will be available for replay on Soleno's website.
Soleno Therapeutics (NASDAQ: SLNO), azienda biofarmaceutica specializzata in terapie per malattie rare, ha annunciato la partecipazione a cinque importanti conferenze per investitori nel settore sanitario nel corso di settembre 2025.
L'azienda terrà presentazioni in formato fireside chat al Cantor Global Healthcare Conference (3 settembre), al Wells Fargo Healthcare Conference (4 settembre), all'H.C. Wainwright Global Investment Conference (8 settembre), al Baird Global Healthcare Conference (9 settembre) e al Bernstein Healthcare Forum (25 settembre).
I webcast degli eventi Cantor e Wells Fargo saranno disponibili in replay sul sito web di Soleno.
Soleno Therapeutics (NASDAQ: SLNO), una compañía biofarmacéutica centrada en terapias para enfermedades raras, ha anunciado su participación en cinco importantes conferencias para inversores del sector sanitario durante septiembre de 2025.
La compañía realizará presentaciones en formato fireside chat en el Cantor Global Healthcare Conference (3 de septiembre), el Wells Fargo Healthcare Conference (4 de septiembre), el H.C. Wainwright Global Investment Conference (8 de septiembre), el Baird Global Healthcare Conference (9 de septiembre) y el Bernstein Healthcare Forum (25 de septiembre).
Los webcasts de los eventos de Cantor y Wells Fargo estarán disponibles para reproducción en el sitio web de Soleno.
Soleno Therapeutics (NASDAQ: SLNO), 희귀질환 치료제에 주력하는 바이오제약사인 Soleno가 2025년 9월에 개최되는 주요 헬스케어 투자자 컨퍼런스 5곳에 참가한다고 발표했습니다.
회사는 Cantor Global Healthcare Conference(9월 3일), Wells Fargo Healthcare Conference(9월 4일), H.C. Wainwright Global Investment Conference(9월 8일), Baird Global Healthcare Conference(9월 9일), 그리고 Bernstein Healthcare Forum(9월 25일)에서 모두 파이어사이드 챗 형식으로 발표를 진행합니다.
Cantor와 Wells Fargo 행사에 대한 웹캐스트는 Soleno 웹사이트에서 다시보기로 제공될 예정입니다.
Soleno Therapeutics (NASDAQ: SLNO), une société biopharmaceutique spécialisée dans les traitements des maladies rares, a annoncé sa participation à cinq grandes conférences pour investisseurs du secteur de la santé en septembre 2025.
La société présentera sous forme de « fireside chat » au Cantor Global Healthcare Conference (3 septembre), au Wells Fargo Healthcare Conference (4 septembre), au H.C. Wainwright Global Investment Conference (8 septembre), au Baird Global Healthcare Conference (9 septembre) et au Bernstein Healthcare Forum (25 septembre).
Les webcasts des événements Cantor et Wells Fargo seront disponibles en replay sur le site web de Soleno.
Soleno Therapeutics (NASDAQ: SLNO), ein biopharmazeutisches Unternehmen mit Schwerpunkt auf Therapien für seltene Krankheiten, hat seine Teilnahme an fünf wichtigen Gesundheits-Investorenkonferenzen im September 2025 angekündigt.
Das Unternehmen wird beim Cantor Global Healthcare Conference (3. September), beim Wells Fargo Healthcare Conference (4. September), beim H.C. Wainwright Global Investment Conference (8. September), beim Baird Global Healthcare Conference (9. September) und beim Bernstein Healthcare Forum (25. September) jeweils in Form eines Fireside Chats präsentieren.
Webcasts der Cantor- und Wells Fargo-Veranstaltungen werden auf der Website von Soleno als Wiederholung verfügbar sein.
- None.
- None.
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in September:
Cantor Global Healthcare Conference
Presentation Date: Wednesday, September 3, 2025 at 1:00 PM ET
Presentation Format: Fireside Chat
Webcast: Here
Wells Fargo Healthcare Conference
Presentation Date: Thursday, September 4, 2025 at 1:30 PM ET
Presentation Format: Fireside Chat
Webcast: Here
H.C. Wainwright 27th Annual Global Investment Conference
Presentation Date: Monday, September 8, 2025 at 4:00 PM ET
Presentation Format: Fireside Chat
Baird Global Healthcare Conference
Presentation Date: Tuesday, September 9, 2025 at 2:00 PM ET
Presentation Format: Fireside Chat
Bernstein 2nd Annual Healthcare Forum
Presentation Date: Thursday, September 25, 2025 at 9:40 AM ET
Presentation Format: Fireside Chat
Replays of the Cantor and Wells Fargo events will be available in the Investors section on the Company’s website at www.soleno.life.
About Soleno Therapeutics, Inc.
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The Company’s first commercial product, VYKAT™ XR (diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome. For more information, please visit www.soleno.life.
Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578
FAQ
When is Soleno Therapeutics (SLNO) presenting at the Cantor Global Healthcare Conference 2025?
How many investor conferences will Soleno Therapeutics (SLNO) attend in September 2025?
Where can investors access Soleno Therapeutics' (SLNO) conference presentations?
What is the format of Soleno Therapeutics' (SLNO) conference presentations?
